Substituted n-carboxyalkylpeptidyl derivatives as...

Details Substituted n-carboxyalkylpeptidyl derivatives as... Substituted n-carboxyalkylpeptidyl derivatives as...

C - Chemistry, Metallurgy

07

K

C07K 5/062 (2006.01) A61K 38/05 (2006.01) C07K 5/02 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2102890

2102890 9221360 PCTABS00017 Novel N-carboxyalkylpeptidyl compounds of formula (I) are found to be useful inhibitors of matrix metalloendoproteinase-mediated diseases including osteoarthritis, rheumatoid arthritis, septic arthritis, tumor invasion in certain cancers, periodontal disease, corneal ulceration, proteinuria, dystrophobic epidermolysis bullosa, and coronary thrombosis associated with atherosclerotic plaque rupture. The matrix metalloendoproteinases are a family of zinc-containing proteinases including but not limited to stromelysin, collagenase, and gelatinase, that are capable of degrading the major components of articular cartilage and basement membranes. The inhibitors claimed herein may also be useful in preventing the pathological sequelae following a traumatic injury that could lead to a permanent disability. These compounds may also have utility as a means for birth control by preventing ovulation or implantation.

Affiliated with

Also associated with

Rating

Substituted n-carboxyalkylpeptidyl derivatives as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted n-carboxyalkylpeptidyl derivatives as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted n-carboxyalkylpeptidyl derivatives as... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1948042